Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Steven Yakubov
Added:
5 years ago
Dr Steven Yakubov (OhioHealth Riverside Methodist Hospital, Columbus, OH, US) discusses 1-year outcomes of TAVR vs SAVR in patients at intermediate surgical risk - a propensity-match analysis from the SURTAVI trial.
Filmed on site at CRT 2019 by Radcliffe Cardiology
Questions:
1. Why did you conduct this analysis?
2. How was data collected and analysed?
3. What were your findings?
4. How…
View more
Author(s):
John Rawlins
,
Jehangir Din
,
Suneel Talwar
,
et al
Added:
3 years ago
A bifurcation lesion within the coronary arterial circulation is defined as a stenosis occurring at, or adjacent to, a significant division of a major epicardial coronary artery.1 Bifurcation lesions account for 1–20% of all percutaneous coronary interventions (PCIs), and treatment remain technically challenging despite advances in PCI techniques and third-generation drug-eluting stent (DES)…
View more
Author(s):
Farouc Jaffer
Added:
5 years ago
Dr. Farouc Jaffer discussesProcedural Outcomes of Multiple CTO Intervention Carried Out in the Same Procedure: Insight From a Multicenter CTO Registry
Filmed by Radcliffe Cardiology on-site at ACC 2018 in Orlando, US.
View more
Author(s):
Federico M Asch
Added:
5 years ago
Dr Federico M Asch (Washington Hospital Center, Washington DC, US) discusses echocardiographic outcomes from the COAPT trial - mitral regurgitation after MitraClip implantation in patients with HF and secondary mitral regurgitation.Filmed on-site at ACC 2019 by Radcliffe Cardiology.
Videographer: Josh Birch
Educational Lead: Liam O'Neill, Chief Operating Officer
View more
Author(s):
Apostolos Tzikas
,
Darren Mylotte
,
Martin Bergmann
Added:
3 years ago
Atrial fibrillation (AF), the most common arrhythmia, is associated with a significantly increased risk of morbidity and mortality due to a fivefold increase in the frequency of thromboembolic stroke.1 The gold standard treatment for the prevention of AF-related thromboembolism is oral anticoagulation (OAC), based on an individualised patient risk assessment with either the CHADS2 or the CHA2DS2…
View more
Author(s):
Simon Kennon
,
John Webb
Added:
8 years ago
The SAPIEN 3 Trials - One Year Outcomes
Simon Kennon and John Webb at Euro PCR 2015
Dr Webb has kindly supplied access to this supporting slide set for viewers of this interview:
View more
BIO-RESORT: 5Y Outcomes
Author(s):
Eline H Ploumen
Added:
2 years ago
Video
Author(s):
Harriette Van Spall
,
Steven E Nissen
Added:
1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principal investigator, Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) to have a deep dive into the practice-changing CLEAR-Outcomes trial (NCT02993406).The Phase 3 CLEAR-Outcomes trial was conducted to evaluate the impact of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular…
View more
Author(s):
Aaisha Opel
Added:
5 years ago
Dr Aaisha Opel discusses 'Empowering Teams to Improve Atrial Fibrillaiton Ablation Efficiency and Outcomes' at EHRA 2018.
View more